All stock lists
Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
Healthcare · Biotechnology
312.50+1.00 (+0.32%)
Insider Score
––Not scored
KRYS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
KRYS Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 119.22 M | 116.36 M | 107.11 M | 97.80 M | 96.04 M | 88.18 M |
| Revenue Growth (YoY) | 24.14 % | 31.95 % | 17.52 % | 16.65 % | 36.65 % | 94.88 % |
| Cost of Revenue | 6.44 M | 6.32 M | 10.92 M | 5.66 M | 7.17 M | 5.03 M |
| Gross Profit | 112.78 M | 110.03 M | 96.19 M | 92.14 M | 88.88 M | 83.16 M |
| SG&A Expense | 39.85 M | 41.01 M | 41.28 M | 37.58 M | 35.16 M | 32.72 M |
| R&D Expense | 14.52 M | 15.33 M | 16.20 M | 13.19 M | 14.41 M | 14.26 M |
| Operating Expenses | 54.37 M | 56.34 M | 51.75 M | 50.76 M | 49.57 M | 46.98 M |
| Operating Income | 58.42 M | 53.69 M | 44.44 M | 41.37 M | 39.31 M | 36.18 M |
| Pretax Income | 66.08 M | 61.44 M | 51.13 M | 47.97 M | 46.77 M | 43.60 M |
| Tax Provision | 11.31 M | 5.51 M | -268.00 K | -31.40 M | 8.44 M | 7.86 M |
| Net Income | 54.77 M | 55.93 M | 51.40 M | 79.36 M | 38.33 M | 35.73 M |
| EPS (Basic) | 1.85 | 1.91 | 1.77 | 2.74 | 1.33 | 1.24 |
| EPS (Diluted) | 1.79 | 1.83 | 1.70 | 2.66 | 1.29 | 1.20 |
| Shares Outstanding | 29.53 M | 29.29 M | 28.94 M | 28.95 M | 28.91 M | 28.82 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.